Slide 1: FY2012 (6/11-5/12) Results Explanatory Meeting
FY2012 (6/11-5/12) Results Explanatory Meeting July 20, 2012 The earnings forecasts appearing in this material are based on the business environment at the present time, and there is the possibility that actual earnings may differ from forecasts for various reasons. Furthermore, only inquiries in Ja
Slide 2: FY2012 Consolidated Results
FY2012 Consolidated Results (06/2011 – 05/2012) 2
Slide 3: FY2012 Consolidated Profit and Loss Statement
1. FY2012 Consolidated Profit and Loss Statement Existing Existingstores storesshow showsteady steadygrowth, growth, Return Returnon onassets assets [ROA] [ROA] 14.5% 14.5% achieving higher sales and profit achieving higher sales and profit Return on equity [ROE] 14.1% Return on equity [ROE] 14.1% F
Slide 4: FY2012 Consolidated Balance Sheet
2. FY2012 Consolidated Balance Sheet (million yen) Main Maincauses causesof ofchanges changes May 31, 2011 May 31, 2012 Change (consolidate) (consolidated) Total Totalassets assets Total assets 62,626 68,030 +5,404 Opening Openingofof33 33new newstores, stores,etc. etc. Fixed Fixed assets +2,192 mil
Slide 5: FY2012 Consolidated Statement of Cash Flows
3. FY2012 Consolidated Statement of Cash Flows (million yen) Major Majorbreakdown breakdown FY2011 FY2012 Change (consolidated) (consolidated) Net profit before taxes 9,165 million yen Net profit before taxes 9,165 million yen Depreciation 2,121 million yen Cash flow from Depreciation 2,121
Slide 6: Results for Each Business Company
Results for Each Business Company 6
Slide 7: FY2012 Profit and Loss Statement (Create SD)
1. FY2012 Profit and Loss Statement (Create SD) FY2011 FY2012 YoY % of Share Share (million yen) (million yen) change projection (%) (%) (%) (%) Net sales 154,094 100.0 168,711 100.0 109.5 102.1 Gross profit 41,516 26.9 45,155 26.8 108.8 103.0 SG&A expenses 33,422 21.7 36,301 21.5 108.6 100.1 Operat
Slide 8: Sales (Create SD)
2. Sales Create SD Concentrated Concentratedon onmeasures measuresfor forboosting boostingof ofsales salesand andnumber numberof ofcustomers customers Sales Salesatatexisting existingstores storesrose rose1.6%, 1.6%,number numberof ofcustomers customers0.2%, 0.2%,and andaverage averagespending spend
Slide 9: Sales by Segment
3. Sales by Segment Create SD Strengthening Strengtheningofofthe theselection selectionof ofgoods goodscentering centeringon onfood foodproducts productsand anddaily dailyproducts products Working for boosting of sales and number of customers Working for boosting of sales and number of customers FY2
Slide 10: SG&A Expenses
4. SG&A Expenses Create SD As Asaaresult resultof ofefforts effortsto toenhance enhanceprofit profitstructure, structure,SG&A SG&Aexpense expenseratio ratiodecreased decreasedby by 0.2 percentage points to 21.5% 0.2 percentage points to 21.5% Yearly change in SG&A Expenses and SG&A Expenses ratio Ba
Slide 11: New Store Openings
5. New Store Openings Create SD 33 33new newstores storeswere wereopened opened(of (ofwhich which55were werededicated dedicatedprescription prescriptiondrug drugstores) stores) New store openings by area Kanagawa Tokyo Shizuoka Saitama Chiba Gunma Ibaraki Total New stores OTC 14 6 6 0 2 0 0 28 dedic
Slide 12: Prescription Operations
6. Prescription Operations Create SD 13 13new newstores storesopened 61 opened (5 dedicated prescription drug stores and 61stores storesat atthe theend endof ofFY2012 FY2012 (22 dedicated prescription drug stores and 8(5in-store dedicated prescription drug stores and pharmacies) (22in-store 39 dedic
Slide 13: Assisted-living Fee-charging Nursing Home and Preventive Nursing Business
7. Assisted-living fee-charging nursing home Welllife SALON DAY and Preventive Nursing Business FY2012 Difference from Share projection (million yen) (%) (million yen) Net sales 1,078 100.0 -143 Operating profit -79 － -43 Recurring profit -75 － -33 Net profit -146 － -12 * The income statement is bas
Slide 14: Growth Strategy
Growth Strategy CREATE SD HOLDINGS
Slide 15: Growth Strategy – Drug Store Operations
1. Growth Strategy – Drug Store Operations 1. Opening 40 new stores -Targeting 8–10% growth in sales- ・Develop stores with focus on Kanagawa, Tokyo, and Shizuoka ・Opening small stores in the areas where shopping is inconvenient ・Opening large-scale stores with more than 350 tsubo Minato Ward Shibada
Slide 16: Growth Strategy – Prescription Operations
2. Growth Strategy – Prescription Operations 1. Opening 31 new stores ・6 dedicated prescription drug stores and 25 in-store pharmacies ・In-house development of two medical malls 2. Newly engaging with more than 11 nursing homes ・Increasing the home medication guidance fee 3. Improving profitability
Slide 17: Growth Strategy – Nursing Operations
3. Growth Strategy – Nursing Operations Assisted-living fee-charging nursing home 1. Measures to increase occupancy rates ・Offering a more flexible price system including the “zero entry fee” plan (responding to legal changes) ・Strengthening marketing promotion and advertising Preventive nursing bus
Slide 18: Create Group Medium-term Vision
4. Create Group Medium-term Vision Creating Creatingaasystem systemto tocontribute contributeto tosociety societyas asaacomprehensive comprehensivehealthcare healthcare support supportcompany companyinincooperation cooperationwith withcommunity communitymedical medicalfacilities facilities Operation
Slide 19: Net sales and recurring profit; Number of stores
Net sales and recurring profit Bar graph: Net sales Graph: Recurring profit (million yen) (million yen) 2 4 0 ,0 0 0 1 4 ,0 0 0 12,000 2 2 0 ,0 0 0 million yen 1 2 ,0 0 0 10,005 2 0 0 ,0 0 0 9,441 8,396 8,744 1 0 ,0 0 0 1 8 0 ,0 0 0 7,860 7,610 million yen 8 ,0 0 0 1 6 0 ,0 0 0 221,000 million yen 6
Slide 20: FY2013 Forecasts (Consolidated)
FY2013 Forecasts (Consolidated) FY2012 FY2013 (consolidated results) (consolidated projection) Share Share YoY Change (million yen) (million yen) (%) (%) (%) Net sales 169,790 100.0 183,403 100.0 108.0 Gross profit 45,123 26.6 48,752 26.6 108.0 SG&A expenses 35,999 21.2 39,027 21.3 108.4 Operating p
Slide 21: FY2013 Projections (Drug Stores and Prescription Operations)
FY2013 Projections (Create SD – Drug Stores and Prescription Operations) FY2012 FY2013 (results) (projection) Share Share YoY change (million yen) (million yen) (%) (%) (%) Net sales 168,711 100.0 182,176 100.0 108.0 Gross profit 45,155 26.8 48,715 26.7 107.9 SG&A expenses 36,301 21.5 39,368 21.6 10
Slide 22: FY2013 Projections (Nursing Home and Preventive Nursing)
FY2013 Projections (Assisted-living Fee-charging Nursing Home and Preventive Nursing Business) FY2012 FY2013 (results) (projection) Share Share YoY change (million yen) (million yen) (%) (%) (%) Net sales 1,078 100.0 1,226 100.0 113.7 Operating profit -79 － -10 － － Recurring profit -75 － -18 － － Net